Efficacy of tocilizumab treatment in COVID-19 patients with cytokine release syndrome

Efficacy of tocilizumab treatment in COVID-19 patients with cytokine release syndrome

Background/Aim: Cytokine release syndrome, a potentially life-threatening condition in SARS‐CoV‐2 (COVID-19) patients, plays a critical role that may lead to the prioritization of tocilizumab (TCZ) in the treatment of this disease. We aimed to present our TCZ-treated SARS‐CoV‐2 patients’ data that m...

Full description

Bibliographic Details
Main Authors: Hayat Kumbasar, Nilgün Işıksaçan, Mehmet Hurşitoğlu, Semsi Karabela, Ozan Cemal Icacan, Melek Yalçın Mutlu, Faruk Karandere, Esra Canbolat Ünlü, Zuhal Yeşilbağ, Fatma Ekşi, Hakan Koçoğlu, Betül Erişmiş
Format: Article
Language:English
Published: Journal of Surgery and Medicine 2021-03-01
Series:Journal of Surgery and Medicine
Subjects:
covid-19
tocilizumab
sars-cov-2
cytokine release syndrome
Online Access:https://dergipark.org.tr/en/pub/josam/issue/60662/876637

Internet

https://dergipark.org.tr/en/pub/josam/issue/60662/876637

Similar Items